Reduced antiplatelet effect of aspirin at the end of the dosing interval in CAD patients with type 2 diabetes mellitus.

Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdato5 okt. 2013
StatusAccepteret/In press - 5 okt. 2013

Citationsformater